Boryung and Lilly will co-promote the pancreatic and lung cancer treatment ‘Gemzar’

Boryung Pharmaceutical and Lilly Korea will jointly promote the pancreatic and lung cancer treatment ‘Gemzar.’

Boryung Pharmaceutical (President Tae-hong Choi) and Lilly Korea(President Paul Henry Huibers) held the co-promotion contract ceremony for ‘Gemzar (generic name: gemcitabine)’ at the Boryung headquarters.

‘Gemzar’ has indications for pancreatic cancer, bladder cancer, breast cancer, ...